Stock screener

QGEN

Conviction 67HealthcareScan · Thu, Sep 24, 2026

Qiagen N.v. (QGEN) closed at $44.56 (+1.93%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 57, RS Rating 62, -20.0% from its 52-week high, -1.4% year to date. Sector: Healthcare · Diagnostics & Research.

QGEN$44.56+1.93%
ResistanceSupportVol 14
63 bars
Vol MA14 1.66M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
QIAGEN N.V.Diagnostics & Researchwww.qiagen.com ↗
Price44.56
Change+1.93%
Gap+0.85%
Rel volume0.71×
Avg volume1.69M
Avg $ vol73.47M
SMA 2043.31
SMA 5042.70
SMA 20042.50
Price vs 50+4.35%
Price vs 200+4.84%
MA stackbullish
50/200 crossgolden · 3d
Supertrendup · 41.26
RSI (14)57
MACD hist0.10
MACD crossbull · 3d
Stoch %K / %D81 / 69
ADX (14)11
+DI / −DI26 / 21
RSI divergence—
MACD divergence—
ATR %2.74%
ADR %2.22%
52w high55.66
52w low32.63
From 52w high-19.95%
Above 52w low+36.55%
New 52w highNo
SqueezeOn · 5d
Bollinger width7.44%
%B0.89
Donchian pos80.77%
Donchian high45.23
Donchian low41.74
AVWAP (52w high)42.46
vs AVWAP high+4.94%
AVWAP (52w low)40.34
vs AVWAP low+10.45%
OBV trendUp
Chaikin MF (20)-0.05
Today vs 20d0.71×
Avg vol (14d)1.66M
Avg vol (20d)1.69M
Avg $ vol (20d)73.47M
Market cap9.66B
RS Rating62 / 99
RS 3m (vs SPY)+9.93%
RS 6m (vs SPY)-7.16%
RS line new highNo
Trend template5/8
Technical rank74.4
1 week+0.39%
1 month+2.07%
3 months+14.42%
6 months+9.66%
1 year-2.31%
YTD-1.41%
P/E—
P/B2.56
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq0.44
Current3.90
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target44.25
Target upside-0.68%
Analyst ratingHold
Institutional75.42%
Ent. value10.48B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDiagnostics & Research
ExchangeNYSE
Shares out206.07M
Employees5.5K
ListedFri, Jun 28, 1996
Free float221.31M
Float %99.6%
Short interest7.51M
Days to cover2.2d
Short volume54.8%
Squeeze score28 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.62 vs $0.60
Last surprise+3.3% beat
Setup gradeB
Conviction67 / 100
Pattern quality—
Tech rank74.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance45.22
Support41.15
Days since event—
Candle confirm—

Congress activity

Disclosed STOCK Act trades in QGEN

All disclosures →
No recent disclosed trades by Congress in QGEN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QGEN

No recent insider (Form 4) filings in QGEN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in QGEN · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.